TRICHECO: Efficacy and Safety of CHF 5993 100/6/12.5 ?g HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting 2-agonists (clinicaltrials.gov) - Jul 9, 2026 - P3 | N=554 | Recruiting | Sponsor: Chiesi Farmaceutici S.p.A. | Not yet recruiting ➔ Recruiting
Enrollment open • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
|